<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092023000700610</article-id>
<article-id pub-id-type="doi">10.35366/114864</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Hemorragia alveolar difusa, ¿cómo tratarla, cuando tiene múltiples etiologías?]]></article-title>
<article-title xml:lang="en"><![CDATA[Diffuse alveolar hemorrhage, how to treat it, when you have multiple etiologies?]]></article-title>
<article-title xml:lang="pt"><![CDATA[Hemorragia alveolar difusa, como tratar, quando tem múltiplas etiologias?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quezada Patiño]]></surname>
<given-names><![CDATA[María Verónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Zúñiga]]></surname>
<given-names><![CDATA[Martín de Jesús]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital General de México «Dr. Eduardo Liceaga»  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>37</volume>
<numero>7</numero>
<fpage>610</fpage>
<lpage>613</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092023000700610&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092023000700610&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092023000700610&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La hemorragia alveolar difusa es una entidad poco frecuente, con alta mortalidad. Clínicamente se caracteriza por disnea aguda grave que se acompaña de hipoxemia, disminución de la hemoglobina y hemoptisis. Las causas más frecuentes son por vasculitis, enfermedades reumatológicas, farmacológicas, elevación de la presión del ventrículo izquierdo (falla cardiaca), entre otras. Se describe el caso clínico de un hombre de 26 años, con diagnósticos de lupus eritematoso, síndrome antifosfolípidos, tromboembolia pulmonar crónica e insuficiencia cardiaca crónica y síndrome de sobrecoagulación, que desarrolla hemorragia alveolar difusa y tromboembolia pulmonar de alto riesgo, con la finalidad de ejemplificar los retos para el tratamiento de la hemorragia alveolar difusa.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Diffuse alveolar hemorrhage is a rare entity with high mortality. Clinically it is characterized by severe dyspnea that is accompanied by hypoxemia, decreased hemoglobin, and hemoptysis. The most frequent causes are vasculitis, rheumatological, pharmacological diseases, elevation of left ventricular pressure (heart failure), among others. The clinical case of a 26-year-old man with diagnoses of lupus erythematosus, antiphospholipid syndrome, chronic pulmonary thromboembolism, and chronic heart failure and over coagulation syndrome who develops diffuse alveolar hemorrhage and high-risk pulmonary thromboembolism is described, in order to exemplify the challenges for the treatment of diffuse alveolar hemorrhage.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: A hemorragia alveolar difusa é uma entidade rara, com alta mortalidade. Clinicamente, é caracterizada por dispneia aquosa grave acompanhada de hipoxemia, diminuição da hemoglobina e hemoptise. As causas mais comuns são vasculites, doenças reumatológicas e farmacológicas, elevação da pressão ventricular esquerda (insuficiência cardíaca), entre outras. É descrito o caso clínico de um homem de 26 anos, com diagnóstico de lúpus eritematoso, síndrome antifosfolípide, tromboembolismo pulmonar crônico e insuficiência cardíaca crônica e síndrome de supercoagulação que evolui com hemorragia alveolar difusa e tromboembolismo pulmonar de alto risco, com o objetivo de exemplificar os desafios para o tratamento da hemorragia alveolar difusa.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[hemorragia alveolar]]></kwd>
<kwd lng="es"><![CDATA[hemoptisis masiva]]></kwd>
<kwd lng="es"><![CDATA[lupus eritematoso]]></kwd>
<kwd lng="en"><![CDATA[alveolar hemorrhage]]></kwd>
<kwd lng="en"><![CDATA[massive hemoptysis]]></kwd>
<kwd lng="en"><![CDATA[lupus erythematosus]]></kwd>
<kwd lng="pt"><![CDATA[hemorragia alveolar]]></kwd>
<kwd lng="pt"><![CDATA[hemoptise maciça]]></kwd>
<kwd lng="pt"><![CDATA[lúpus eritematoso]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study]]></article-title>
<source><![CDATA[Arthritis Res Ther]]></source>
<year>2021</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>138</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguilera-Pickens]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Abud-Mendoza]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifestaciones pulmonares en lupus eritematoso sistémico: afección pleural, neumonitis aguda, enfermedad intersticial crónica y hemorragia alveolar difusa]]></article-title>
<source><![CDATA[Reumatol Clin]]></source>
<year>2018</year>
<volume>14</volume>
<page-range>294-300</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al-Adhoubi]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
<name>
<surname><![CDATA[Bystrom]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies]]></article-title>
<source><![CDATA[Lupus]]></source>
<year>2020</year>
<volume>29</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>355-63</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scapa]]></surname>
<given-names><![CDATA[JV]]></given-names>
</name>
<name>
<surname><![CDATA[Fishbein]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Wallace]]></surname>
<given-names><![CDATA[WD]]></given-names>
</name>
<name>
<surname><![CDATA[Fishbein]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diffuse alveolar hemorrhage and pulmonary vasculitides: histopathologic findings]]></article-title>
<source><![CDATA[Semin Respir Crit Care Med]]></source>
<year>2018</year>
<volume>39</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>425-33</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of diffuse alveolar hemorrhage: controlling inflammation and obtaining rapid and effective hemostasis]]></article-title>
<source><![CDATA[Int J Mol Sci]]></source>
<year>2021</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>793</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nasser]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cottin]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alveolar hemorrhage in vasculitis (primary and secondary)]]></article-title>
<source><![CDATA[Semin Respir Crit Care Med]]></source>
<year>2018</year>
<volume>39</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>482-93</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Martínez]]></surname>
<given-names><![CDATA[MU]]></given-names>
</name>
<name>
<surname><![CDATA[Ostdam]]></surname>
<given-names><![CDATA[DAH]]></given-names>
</name>
<name>
<surname><![CDATA[Abud-Mendoza]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diffuse alveolar hemorrhage in autoimmune diseases]]></article-title>
<source><![CDATA[Curr Rheumatol Rep]]></source>
<year>2017</year>
<volume>19</volume>
<page-range>27</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ednalino]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Yip]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Carsons]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic review of diffuse alveolar hemorrhage in systemic lupus erythematosus: focus on outcome and therapy]]></article-title>
<source><![CDATA[J Clin Rheumatol]]></source>
<year>2015</year>
<volume>21</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>305-10</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reibaldi]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Sager]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Calvo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Roverano]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Paira]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hemorragia alveolar difusa en pacientes con lupus eritematoso sistémico]]></article-title>
<source><![CDATA[Reumatol Clin]]></source>
<year>2022</year>
<volume>18</volume>
<page-range>84-90</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
